Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
17,417,453
-
Total 13F shares
-
16,282,884
-
Share change
-
+87,364
-
Total reported value
-
$54,051,121
-
Price per share
-
$3.32
-
Number of holders
-
27
-
Value change
-
+$296,694
-
Number of buys
-
8
-
Number of sells
-
10
Institutional Holders of Insight Molecular Diagnostics Inc. - Common Stock (IMDX) as of Q3 2025
As of 30 Sep 2025,
Insight Molecular Diagnostics Inc. - Common Stock (IMDX) was held by
27 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
16,282,884 shares.
The largest 10 holders included
BROADWOOD CAPITAL INC, AWM Investment Company, Inc., PURA VIDA INVESTMENTS, LLC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock, Inc., MILLENNIUM MANAGEMENT LLC, MORGAN STANLEY, FNY Investment Advisers, LLC, and STATE STREET CORP.
This page lists
27
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.